In vitro labeling and MRI of mesenchymal stem cells from human umbilical cord blood

被引:120
作者
Ju, Shenghong
Teng, Gaojun [1 ]
Zhang, Yu
Ma, Ming
Chen, Feng
Ni, Yicheng
机构
[1] SE Univ, Zhongda Hosp, Dept Radiol, Lab Mol Imaging, Nanjing 210009, Peoples R China
[2] SE Univ, Lab Mol & Biomol Elect, Nanjing 210009, Peoples R China
[3] Katholieke Univ Leuven, Univ Hosp, Dept Radiol, B-3000 Louvain, Belgium
基金
中国国家自然科学基金;
关键词
mesenchymal stem cells; magnetic resonance; cell labeling; iron oxide particles;
D O I
10.1016/j.mri.2005.12.017
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];
摘要
Objective: The aim of this study was to label human umbilical cord blood mesenchymal stem cells (MSCs) with poly-L-lysine (PLL)conjugated superparamagnetic iron oxide particles and to obtain magnetic resonance (MR) images of the labeled MSCs' suspension at 1.5 T. Material and Methods: PLL was conjugated with iron oxide to form superparamagnetic particles called Fe2O3-PLL. Human umbilical cord blood MSCs were isolated, purified, expanded and incubated with Fe2O3-PLL. Prussian blue stain was performed to show intracellular iron; spectrometry was used to quantify iron uptake within cells. Tetrazolium salt (MTT) assay was applied to evaluate toxicity and proliferation of MSCs labeled with various concentrations of Fe2O3-PLL. The cell apoptosis rate was determined by annexin V/propichium iodide (PI) double staining method. Vials containing cells underwent MR imaging (MRI) with T-1, T-2 and T-2* weighted MRI. Results: Iron-containing intracytoplasmatic vesicles could be observed clearly with Prussian blue staining in all samples except the unlabeled control. The iron content per cell determined by spectrometry was 64.51 +/- 10.32 pg. Among MSCs with and without labeling of various concentrations of Fe2O3-PLL, MTT values of light absorption had no statistically significant difference (Kruskal-Wallis test, chi(2) = 10.35, P=. 17). A concentration at 20 mu g/ml of iron appeared most suitable for incubating cells. Of labeled and unlabeled MSCs, the early [annexin V-fluorescein isothiocyanate (FITC)-positive/PI-negative] and late (annexin V-FITC-positive/PI-positive) apoptotic cells were 10.34 +/- 0.43%/ 11.36 +/- 1.30% and 4.01 +/- 1.76%/2.98 +/- 1.37%, respectively, and there were no significant differences between them (P>.05). T-2 weighted image (WI) and T-2*WI demonstrated significant decrease of signal intensity (SI) in vials containing 1 X 10(6) (1 day), 1 X 10(6) (8 days) and 5 X 10(5) labeled cells, in comparison with unlabeled cells (P<.05). The percentage change of SI (Delta SI) was significantly higher in 10(6) labeled cells after 1-day culture than that in the same number of labeled cells after 8-day culture and that in 5 X 10(5) labeled cells, particularly on T-2*WI (P<.05). Among pulse sequences, T-2*WI demonstrated the highest Delta SI (P<.05). Conclusion: The human umbilical cord blood MSCs can be labeled with Fe2O3-PLL without significant change in viability and apoptosis. The suspension of labeled MSCs can be imaged with standard 1.5-T MR equipment. (C) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:611 / 617
页数:7
相关论文
共 27 条
[1]
Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging [J].
Arbab, AS ;
Bashaw, LA ;
Miller, BR ;
Jordan, EK ;
Lewis, BK ;
Kalish, H ;
Frank, JA .
RADIOLOGY, 2003, 229 (03) :838-846
[2]
Bicknese AR, 2002, CELL TRANSPLANT, V11, P261
[3]
Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells [J].
Bulte, JWM ;
Douglas, T ;
Witwer, B ;
Zhang, SC ;
Strable, E ;
Lewis, BK ;
Zywicke, H ;
Miller, B ;
van Gelderen, P ;
Moskowitz, BM ;
Duncan, ID ;
Frank, JA .
NATURE BIOTECHNOLOGY, 2001, 19 (12) :1141-1147
[4]
Monitoring stem cell therapy in vivo using magnetodendrimers as a new class of cellular MR contrast agents [J].
Bulte, JWM ;
Douglas, T ;
Witwer, B ;
Zhang, SC ;
Lewis, BK ;
van Gelderen, P ;
Zywicke, H ;
Duncan, ID ;
Frank, JA .
ACADEMIC RADIOLOGY, 2002, 9 :S332-S335
[5]
Magnetically labeled glial cells as cellular MR contrast agents [J].
Bulte, JWM ;
Zhang, SC ;
van Gelderen, P ;
Herynek, V ;
Jordan, EK ;
Janssen, CHC ;
Duncan, ID ;
Frank, JA .
ACADEMIC RADIOLOGY, 2002, 9 :S148-S150
[6]
Neurotransplantation of magnetically labeled oligodendrocyte progenitors: Magnetic resonance tracking of cell migration and myelination [J].
Bulte, JWM ;
Zhang, SC ;
van Gelderen, P ;
Herynek, V ;
Jordan, EK ;
Duncan, ID ;
Frank, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) :15256-15261
[7]
Targeting of hematopoietic progenitor cells with MR contrast agents [J].
Daldrup-Link, HE ;
Rudelius, M ;
Oostendorp, RAJ ;
Settles, M ;
Piontek, G ;
Metz, S ;
Rosenbrock, H ;
Keller, U ;
Heinzmann, U ;
Rummeny, EJ ;
Schlegel, J ;
Link, TM .
RADIOLOGY, 2003, 228 (03) :760-767
[8]
Mesenchymal stem cells: Biology and potential clinical uses [J].
Deans, RJ ;
Moseley, AB .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (08) :875-884
[9]
Mesenchymal progenitor cells in human umbilical cord blood [J].
Erices, A ;
Conget, P ;
Minguell, JJ .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (01) :235-242
[10]
Clinically applicable labeling of mammalian and stem cells by combining; Superparamagnetic iron oxides and transfection agents [J].
Frank, JA ;
Miller, BR ;
Arbab, AS ;
Zywicke, HA ;
Jordan, EK ;
Lewis, BK ;
Bryant, LH ;
Bulte, JWM .
RADIOLOGY, 2003, 228 (02) :480-487